Morimoto Takeshi

Morimoto Takeshi, Fujikado Takashi, Kanda Hiroyuki, Miyoshi Tomomitsu, Endo Takao, Nishida Kentaro et al.

This study found a new wide-field retinal prosthesis was safe and biocompatible in dogs, showing promise for treating conditions like retinitis pigmentosa, despite system durability issues in animals.

Miki Atsuya, Kumoi Miho, Usui Shinichi, Endo Takao, Kawashima Rumi, Morimoto Takeshi et al.

OCT segmentation errors in RNFL and GCC scans are common, affecting up to 20.7% of scans, and are linked to signal strength, disc size, and disease. Clinicians must review raw OCT images to ensure accuracy.

Morimoto Takeshi, Fukui Takehiro, Matsushita Kenji, Okawa Yoshitaka, Shimojyo Hiroshi, Kusaka Shunji et al.

Transcorneal electrical stimulation effectively assessed residual inner-retinal function in retinal degeneration patients. Higher stimulation thresholds correlated with disease severity, suggesting TES can help select candidates for retinal prostheses.

Morimoto Takeshi, Miyoshi Tomomitsu, Matsuda Satoshi, Tano Yasuo, Fujikado Takashi, Fukuda Yutaka

Transcorneal electrical stimulation (TES) rescued damaged retinal ganglion cells (RGCs) by activating the retina's own IGF-1 production via Müller cells. This offers a new neuroprotective therapy without external growth factors.